These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11085710)

  • 21. Respiratory distress syndrome in near-term infants.
    Rizzo C; Nisini R; Marzetti G
    J Matern Fetal Neonatal Med; 2002 May; 11(5):350-1. PubMed ID: 12389680
    [No Abstract]   [Full Text] [Related]  

  • 22. Surfactant status in preterm neonates recovering from respiratory distress syndrome.
    Verlato G; Cogo PE; Balzani M; Gucciardi A; Burattini I; De Benedictis F; Martiri G; Carnielli VP
    Pediatrics; 2008 Jul; 122(1):102-8. PubMed ID: 18595992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New generation synthetic surfactants.
    Curstedt T; Calkovska A; Johansson J
    Neonatology; 2013; 103(4):327-30. PubMed ID: 23736010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactant for premature infants with respiratory distress.
    Med Lett Drugs Ther; 1990 Jan; 32(809):2-3. PubMed ID: 2294387
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurodevelopmental outcomes of very low birth weight preterm infants treated with poractant alfa versus beractant for respiratory distress syndrome.
    Eras Z; Dizdar EA; Kanmaz G; Guzoglu N; Aksoy HT; Altunkaya GB; Canpolat FE; Dilmen U
    Am J Perinatol; 2014 Jun; 31(6):463-8. PubMed ID: 23884719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant replacement therapy in neonatal respiratory distress syndrome.
    Hellmann J
    Paediatr Anaesth; 1995; 5(2):81-8. PubMed ID: 7489429
    [No Abstract]   [Full Text] [Related]  

  • 27. Surfactant. Evolving issues.
    Kattwinkel J
    Clin Perinatol; 1998 Mar; 25(1):17-32. PubMed ID: 9523072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic surfactants in infants with respiratory distress syndrome.
    Egan EA
    N Engl J Med; 1992 Jun; 326(25):1704; author reply 1704-5. PubMed ID: 1588993
    [No Abstract]   [Full Text] [Related]  

  • 29. Surfactant for the treatment of respiratory distress syndrome.
    Jobe A; Ikegami M
    Am Rev Respir Dis; 1987 Nov; 136(5):1256-75. PubMed ID: 3314618
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of surfactant replacement therapy on the nursery.
    Nightengale B
    Neonatal Netw; 1992 Jun; 11(4):xiii-xvi. PubMed ID: 1608368
    [No Abstract]   [Full Text] [Related]  

  • 31. [Surfactant therapy in respiratory distress syndrome; a review].
    de Winter JP; van Sonderen L; Egberts J; van Bel F
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2010-3. PubMed ID: 1407190
    [No Abstract]   [Full Text] [Related]  

  • 32. Surfactant therapy in the USA: trials and current routines.
    Soll RF
    Biol Neonate; 1997; 71 Suppl 1():1-7. PubMed ID: 9209741
    [No Abstract]   [Full Text] [Related]  

  • 33. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
    Polin RA; Carlo WA; ;
    Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appropriateness of surfactant dosing for preterm babies with respiratory distress syndrome: retrospective cohort study.
    Jourdain G; Zacaria F; Ammar F; De Luca D
    Arch Dis Child Fetal Neonatal Ed; 2016 Mar; 101(2):F182-3. PubMed ID: 26785859
    [No Abstract]   [Full Text] [Related]  

  • 36. Poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
    Dizdar EA; Sari FN; Oguz SS; Dilmen U
    J Paediatr Child Health; 2013 Dec; 49(12):1084. PubMed ID: 24325724
    [No Abstract]   [Full Text] [Related]  

  • 37. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 38. Curosurf.
    Med Lett Drugs Ther; 2000 Mar; 42(1074):27-8. PubMed ID: 10776410
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

  • 40. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.